💨 Abstract

Parexel, a top clinical research organization, plans to expand its Indian operations by 2,000 employees over the next few years. India is seen as a viable alternative for early-stage clinical trials due to geopolitical conflicts like the Russia-Ukraine war and drug companies' efforts to reduce dependence on China. India's clinical trials market is estimated to reach $1.51

Courtesy: theprint.in

Summarized by Einstein Beta 🤖